Edition:
United States

Pfizer Inc (PFE)

PFE on New York Consolidated

43.21USD
15 Nov 2018
Change (% chg)

$0.30 (+0.70%)
Prev Close
$42.91
Open
$42.70
Day's High
$43.38
Day's Low
$42.35
Volume
23,129,816
Avg. Vol
21,487,405
52-wk High
$45.81
52-wk Low
$33.20

Chart for

About

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines, as well as consumer healthcare products. The Company manages its commercial operations through two business... (more)

Overall

Beta: 0.86
Market Cap(Mil.): $252,416.00
Shares Outstanding(Mil.): 5,800.00
Dividend: 0.34
Yield (%): 3.12

Financials

  PFE Industry Sector
P/E (TTM): 18.15 28.14 29.53
EPS (TTM): 2.40 -- --
ROI: 10.25 13.50 13.00
ROE: 21.82 15.26 14.69

Pfizer loses drug patent fight in UK top court, may face claims

LONDON Pfizer lost the final round in a lengthy patent battle in Britain on Wednesday after the country's highest court ruled against it in a case involving its $5 billion-a-year pain drug Lyrica, exposing the company to possible financial claims.

Nov 14 2018

UPDATE 2-Pfizer loses drug patent fight in UK top court, may face claims

* Drugmaker says court decision a setback for innovation (Adds NHS, lawyer comment on possible claims against Pfizer)

Nov 14 2018

Pfizer loses Lyrica drug patent fight in UK Supreme Court

LONDON, Nov 14 Pfizer lost the final round in a long-running patent battle in Britain on Wednesday after the country's highest court ruled against it in a case involving its $5 billion-a-year pain drug Lyrica.

Nov 14 2018

Hikma boosts revenue outlook again, shares climb

Nov 8 Jordanian drugmaker Hikma Pharmaceuticals raised full-year revenue expectations for its injectables division, its largest unit, for the second time in three months as it supplies more opioid painkillers amid a shortage in the United States.

Nov 08 2018

Takeda CEO confident of investor backing for $62 bln Shire deal

LONDON, Nov 5 The boss of Japan's Takeda Pharmaceutical said on Monday he was confident of securing investor backing for its $62 billion acquisition of London-listed Shire, despite some shareholders' fears about the resulting debt burden.

Nov 05 2018

FDA approves Pfizer's treatment for certain lung cancer patients

Pfizer Inc said on Friday the U.S. Food and Drug Administration has approved its lung-cancer treatment for patients with a specific gene mutation who had been previously treated for an aggressive form of the disease.

Nov 02 2018

FDA approves Pfizer's treatment for certain lung cancer patients

Nov 2 Pfizer Inc said on Friday the U.S. Food and Drug Administration has approved its lung-cancer treatment for patients with a specific gene mutation who had been previously treated for an aggressive form of the disease.

Nov 02 2018

Deals of the day-Mergers and acquisitions

Nov 1 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Thursday: ** Canada's Encana Corp will buy Newfield Exploration Co for $5.5 billion, giving the natural gas producer greater access to North America's biggest oilfields, and potentially spurring further deals.

Nov 01 2018

Pfizer weighing sale of women's health portfolio: Bloomberg

U.S. drugmaker Pfizer Inc is considering options, including a sale of its women's health portfolio, Bloomberg reported on Thursday, citing sources familiar with the matter.

Nov 01 2018

Pfizer weighing sale of women's health portfolio - Bloomberg

Nov 1 U.S. drugmaker Pfizer Inc is considering options, including a sale of its women's health portfolio, Bloomberg reported on Thursday, citing sources familiar with the matter.

Nov 01 2018

Earnings vs. Estimates